Tian Hua

Tian Hua

Auto-generated profile, based on publicly available information

Tian Hua

Human Institute, ShanghaiTech University, Shanghai 201210, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Cell
Verified
Journal Article
Closed access
THTian Hua
Tian Hua
XLXiaoting Li
Xiaoting Li
LWLijie Wu
Lijie Wu
CIChristos Iliopoulos-Tsoutsouvas
Christos Iliopoulos-Tsoutsouvas
YWYuxia Wang
Yuxia Wang
ZLZhi-Jie Liu
Zhi-Jie Liu

1 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
KLKaiwen Liu
Kaiwen Liu
LWLijie Wu
Lijie Wu
SYShuguang Yuan
Shuguang Yuan
MWMeng Wu
Meng Wu
YXYueming Xu
Yueming Xu
ZLZhi-Jie Liu
Zhi-Jie Liu

16 September 2022 in Science
Verified
Journal Article
Closed access
WXWeixiu Xu
Weixiu Xu
LWLijie Wu
Lijie Wu
SLShenhui Liu
Shenhui Liu
XLXiao Liu
Xiao Liu
XCXiaoling Cao
Xiaoling Cao
THTian Hua
Tian Hua
Taste sensing is a sophisticated chemosensory process, and bitter taste perception is mediated by type 2 taste receptors (TAS2Rs), or class T G protein–coupled receptors. Understanding the detailed molecular mechanisms behind taste sensation is hindered by a lack of experimental receptor structures. Here, we report the cryo–electron microscopy structures of human TAS2R46 complexed with chimeric mini–G protein gustducin, in both strychnine-bound and apo forms. Several features of TAS2R46 are disclosed, including distinct receptor structures that compare with known GPCRs, a new “toggle switch,” activation-related motifs, and precoupling with mini–G protein gustducin. Furthermore, the dynamic extracellular and more-static intracellular parts of TAS2R46 suggest possible diverse ligand-recognition and activation processes. This study provides a basis for further exploration of other bitter taste receptors and their therapeutic applications.

22 May 2024 in Nature
Verified
Journal Article
Closed access
PDF file
XHXiaolong Hu
Xiaolong Hu
WAWeizhen Ao
Weizhen Ao
MGMingxin Gao
Mingxin Gao
LWLijie Wu
Lijie Wu
YPYuan Pei
Yuan Pei
ZLZhi-Jie Liu
Zhi-Jie Liu

15 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
XLXiaoting Li
Xiaoting Li
HCHao Chang
Hao Chang
JBJara Bouma
Jara Bouma
LPLaura V. de Paus
Laura V. de Paus
PMPartha Mukhopadhyay
Partha Mukhopadhyay
THTian Hua
Tian Hua
Cannabinoid CB2 receptor (CB2R) agonists are investigated as therapeutic agents in the clinic. However, their molecular mode-of-action is not fully understood. Here, we report the discovery of LEI-102, a CB2R agonist, used in conjunction with three other CBR ligands (APD371, HU308, and CP55,940) to investigate the selective CB2R activation by binding kinetics, site-directed mutagenesis, and cryo-EM studies. We identify key residues for CB2R activation. Highly lipophilic HU308 and the endocannabinoids, but not the more polar LEI-102, APD371, and CP55,940, reach the binding pocket through a membrane channel in TM1-TM7. Favorable physico-chemical properties of LEI-102 enable oral efficacy in a chemotherapy-induced nephropathy model. This study delineates the molecular mechanism of CB2R activation by selective agonists and highlights the role of lipophilicity in CB2R engagement. This may have implications for GPCR drug design and sheds light on their activation by endogenous ligands.

1 August 2020 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
JWJingjing Wang
Jingjing Wang
THTian Hua
Tian Hua
ZLZhi-Jie Liu
Zhi-Jie Liu